Skip to content

Clinical research on efficacy of fecal microbiota transplantation for chronic nephritic syndrome

Clinical research on efficacy of fecal microbiota transplantation for chronic nephritic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093395
Enrollment
Unknown
Registered
2024-12-04
Start date
2024-12-16
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic nephritic syndrome

Interventions

Sponsors

The First Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-70 years old; 2. 24-hour urine protein quantification >0.5g; 3. eGFR >=30mL/min/1.73m^2; 4. Voluntarily accept fecal microecological products transplantation treatment.

Exclusion criteria

Exclusion criteria: 1.Malignant tumors; 2.History of neuropsychiatric disorders and alcohol abuse; 3.Patients who have used antibiotics within the last 1 week; 4.Pregnant and lactating women; 5.Concomitant serious diseases of other systems, such as severe hepatic insufficiency and cardiac insufficiency.

Design outcomes

Primary

MeasureTime frame
24-hour urine protein;Blood albumin;

Secondary

MeasureTime frame
Adverse reactions and grading;Blood creatinine;Blood urea;C-reactive protein;Hematuria, proteinuria;Weight;The structural and quantity alterations of intestinal flora pre- and after fecal transplantation;

Countries

China

Contacts

Public ContactYang Yunsheng

The First Medical Center, Chinese PLA General Hospital

sunnyddc@plagh.org+86 10 5549 9305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026